01_MadisonSymposia_WebBanner_1000x220

Organizing Committee

Nissim Benvenisty, MD, PhD
The Hebrew University of Jerusalem, Israel

Robert Blelloch, MD, PhD
University of California, San Francisco, USA

Daniel Marshak, PhD
Consulting & Advisory, USA

Melissa Carpenter, PhD
ElevateBIO & The Carpenter Group, USA

Assem Ziady, PhD
Cincinnati Children’s Hospital Medical Center, USA

John Tisdale, MD
NIH/NHLBI, USA

Shen Shen, PhD
Biogen, USA

Gerhard Bauer, Professor
University of California, School of Medicine, USA


The International Society for Stem Cell Research (ISSCR) and the American Society of Gene and Cell Therapy (ASGCT) are partnering to host a cutting-edge program on the latest advances in regenerative medicine. 

Recent discoveries in stem cell biology are being combined with powerful new gene-editing technologies to bring about potentially transformative new therapies. World-renowned scientists will share their latest advances in three focused two-hour virtual sessions on: Neural Disorders, Cell & Gene Therapy Manufacturing Technologies, and Hematopoietic Diseases and Immuno-Oncology. Join us for this outstanding program of international leaders in gene and cell therapies.

For information on sponsorship opportunities, please email exhibits@isscr.org.


Program

Program 1: Neural Disorders
13 September 2021
10:00 - 12:00 EDT (view your time zone)

Leslie Thompson, PhD
UC Irvine, USA
Malin Parmar, PhD
Lund University, Sweden
Gene Yeo, PhD, MBA
UCSD, USA
Sally Temple, PhD
Neural Stem Cell Institute, USA

Program 2: Cell & Gene Therapy Manufacturing
14 September 2021
10:00 - 12:00 EDT (view your time zone)

Mohamed Abou El-Enein, MD, PhD
University of Southern California, USA
Thomas VanCott, PhD
Catalent Biologics, USA
Melissa Carpenter, PhD
ElevateBio/Carpenter Group Consulting, USA
John Pierciey, BS, MS
Bluebird bio, USA

Program 3: Hematopoietic Diseases and Immuno-Oncology
15 September 2020
10:00 - 12:00 EDT (view your time zone)

Hans-Peter Kiem, MD, PhD
Fred Hutchinson Cancer Center, USA
Simón Méndez-Ferrer, PhD
University of Cambridge, UK
Michel Sadelain, MD, PhD
Memorial Sloan Kettering Cancer Center, USA
Bob Valamehr, PhD
Fate Therapeutics, USA